These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20225199

  • 1. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
    Qian J, Weber D, Cochran R, Hossain D, Bostwick DG.
    Cancer Cytopathol; 2010 Apr 25; 118(2):97-104. PubMed ID: 20225199
    [Abstract] [Full Text] [Related]

  • 2. Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization.
    Muslumanoglu HM, Oner U, Ozalp S, Acikalin MF, Yalcin OT, Ozdemir M, Artan S.
    Eur J Obstet Gynecol Reprod Biol; 2005 May 01; 120(1):107-14. PubMed ID: 15866096
    [Abstract] [Full Text] [Related]

  • 3. Atypical endometrial hyperplasia shares genomic abnormalities with endometrioid carcinoma by comparative genomic hybridization.
    Baloglu H, Cannizzaro LA, Jones J, Koss LG.
    Hum Pathol; 2001 Jun 01; 32(6):615-22. PubMed ID: 11431716
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL.
    Hum Pathol; 2001 Apr 01; 32(4):360-7. PubMed ID: 11331952
    [Abstract] [Full Text] [Related]

  • 8. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB, Qian J, Lieber MM, Bostwick DG.
    Cancer Res; 1997 Feb 01; 57(3):524-31. PubMed ID: 9012485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study.
    Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N.
    Cancer; 2004 Oct 25; 102(5):322-7. PubMed ID: 15376199
    [Abstract] [Full Text] [Related]

  • 19. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E, Salmenkivi K, Vuopala K, Toljamo T, Kuosma E, Norppa H, Knuutila S, Kaleva S, Huuskonen MS, Anttila S.
    Lung Cancer; 2006 Nov 25; 54(2):169-76. PubMed ID: 16935392
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers.
    Susumu N, Aoki D, Noda T, Nagashima Y, Hirao T, Tamada Y, Banno K, Suzuki A, Suzuki N, Tsuda H, Inazawa J, Nozawa S.
    Int J Gynecol Cancer; 2005 Nov 25; 15(1):70-80. PubMed ID: 15670300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.